The global microencapsulation market was valued at USD 8.5 billion in 2020 and is projected to reach USD 15.5 billion by 2025, at a CAGR of 12.9% from 2020 to 2025. The demand for microencapsulation is increasing in various industries due to its wide applications. For instance, encapsulated food ingredients and drugs are used for effective functioning; to prevent product damage until consumption; and to protect the active ingredients from moisture, heat, or other extreme conditions, thus enhancing stability.
Key players in the microencapsulation market include BASF (Germany), Royal Friesland Campina (Netherlands), Syngenta (Switzerland), Koninklije DSM (Netherlands), Givuadan (Switzerland), International Flavours & Fragrances (US), Symrise (Germany), Sensient Technologies (US), Lycored Corp (Israel), Koehler Innovative Solutions (Germany), Balchem Corporation (US), Encapsys (US), Arcade Beauty (US), Ingredion Incorporation (US), Kerry (Ireland), Cargill (US), Firmenich Incorporation (Switzerland), Dupont (US), Aveka Group (US), Advanced Bionutrition Corp (US), Tastetech Encapsulation Solutions (UK), Sphera Encapsulation (Italy), Clextral (France), Vitasquare (Netherlands), and Microtek (US).
Download PDF Brochure:
BASF is a manufacturer of chemical products and has its operations in chemicals, performance products, functional materials & solutions, agricultural solutions, and oil & gas market segments. It operates through six business segments—chemicals, performance products, functional materials & solutions, agricultural solutions, oil & gas, and others. BASF is a microencapsulation products provider and manufacturer of a broad range of products with high-end industrial applications for various business segments such as agriculture, functional material and solutions, chemicals, and performance products. It has a global presence in the microencapsulation business and has operations in all the key markets. The company is engaged in product developments. For instance, the company’s animal nutrition division launched Lucantin NXT product line in the European Union that would gradually follow in other countries. The carotenoid formulation would meet the latest regulation which requires to withdraw ethoxyquin (EQ) as a stabilizer
Royal FrieslandCampina is one of the five largest dairy companies and is fully owned by Zuivelcoöperatie FrieslandCampina U.A. (Netherlands). FrieslandCampina offers products such as dairy-based beverages, infant nutrition, cheese, and desserts. It also offers ingredients and half-finished products to food & pharmaceutical sectors and the infant food industry. The company offers products under various brands segments, namely, consumer brands, ingredients brands, and food service brands. It primarily operates through five segments, namely, consumer products Europe, Middle East & Africa; cheese, butter & milk powder; consumer products Asia; ingredients; and consumer products China. It offers micro-encapsulated products majorly for infant nutrition. The company is focused in expanding its business, for instance, it opened its distribution center in Meppel, Netherlands. The distribution center would help the company cater to the increasing demand in the region and improve the efficiency in the transport of dairy products
Koninklijke DSM is a global science-based company engaged in health, nutrition, and materials businesses. The company operates through four segments—nutrition, materials, innovation center, and corporate activities. Its nutrition segment includes DSM nutritional products and DSM food specialties. The company provides microencapsulated products majorly for the dietary supplement and food & beverage industries. The company’s nutrition segment caters to different end-use application industries that include food, feed, and pharmaceuticals. It has operations in Asia, Australia, Africa, the Americas, and Europe. DSM operates in more than 40 countries with over 100 commercial production facilities. The company is focused in expanding its business for instance, Evonik (Germany) and Royal DSM announced plans to open a commercial-scale production facility for the Omega-3 fatty acids from natural marine algae for animal nutrition in Blair, Nebraska, US. DSM Nutritional Products Ltd. (Switzerland) and Evonik Nutrition & Care GmbH (Germany) would invest nearly USD 200 million in the facility (USD 100 million each over approximately two years).